Gluten Pharmaceutical Private Limited
About Gluten Pharmaceutical Private Limited
Data last updated:
Gluten Pharmaceutical Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24100MP2015PTC033832. Its GSTIN is 23AAFCG8835P2Z0 (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Vikash Urmaliya Dev and Meera Urmaliya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at First Floor Puja Colony Neelbarh, Bhopal, Madhya Pradesh, India – 462001.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.93 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹81,920 (net margin 8.2%) and EBITDA of ₹1.09 Lakh (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFirst Floor Puja Colony Neelbarh, Bhopal, Madhya Pradesh, India – 462001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gluten Pharmaceutical Private Limited
The main business activity of Gluten Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gluten Pharmaceutical Private Limited FY 2025 filings available
Gluten Pharmaceutical Private Limited reported revenue of ₹9.93 Lakh (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Gluten Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 49% growth in the latest year. EBITDA rose 169% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gluten Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.09 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹81,920 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gluten Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gluten Pharmaceutical are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bhura Tea Company Private Limited | ₹9.94 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Assam, India |
| Krishnangi Artwork Private Limited | ₹9.94 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Sterling Tubes and Valves Private Limited | ₹9.93 Lakh (FY 2019) | •••• | •••• | -58.0% | •••• | Ahmedabad, Gujarat, India |
| MLV Tradecorp Limited | ₹9.93 Lakh (FY 2022) | •••• | •••• | -47.0% | •••• | Ahmedabad, Gujarat, India |
| Reydis Pharmaceuticals Private Limited | ₹9.93 Lakh (FY 2025) | •••• | •••• | •••• | Tijara, Rajasthan, India | |
| Gluten Pharmaceutical Private Limited this company | ₹9.93 Lakh (FY 2025) | •••• | •••• | 49.0% | •••• | Bhopal, Madhya Pradesh, India |
| Insectos Systems Private Limited | ₹9.93 Lakh (FY 2024) | •••• | •••• | 73.0% | •••• | Ludhiana, Punjab, India |
| Manekia Agencies Private Limited | ₹9.93 Lakh (FY 2023) | •••• | •••• | 225.0% | •••• | Mumbai, Maharashtra, India |
| Ganpati Dwellings Private Limited | ₹9.93 Lakh (FY 2024) | •••• | •••• | -96.0% | •••• | Noida, Uttar Pradesh, India |
| Chowdhary International Limited | ₹9.93 Lakh (FY 2024) | •••• | •••• | -56.0% | •••• | Kolkata, West Bengal, India |
| Mahavir Tradeline Private Limited | ₹9.93 Lakh (FY 2018) | •••• | •••• | -59.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Gluten Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical Private Limited is audited by GUPTALAKHANI&ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GUPTALAKHANI&ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikash Urmaliya Dev | Director | 12 Feb 2015 | 11 Years 8 Months | Current |
| Meera Urmaliya | Director | 12 Feb 2015 | 11 Years 8 Months | Current |
Ownership and Shareholding of Gluten Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gluten Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Gluten Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Somdev Urmaliya ceased to be Director on 10 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Gluten Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gluten Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gluten Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCG8835P2Z0 | Madhya Pradesh | Active | 12 Jun 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gluten Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gluten Pharmaceutical Private Limited
Gluten Pharmaceutical is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 February 2015 (11+ years old) and is registered under CIN U24100MP2015PTC033832.
Gluten Pharmaceutical reported revenue of ₹9.93 Lakh for FY 2025 (up 49% YoY).
Gluten Pharmaceutical has 2 current directors:
- Vikash Urmaliya Dev - Director
- Meera Urmaliya - Director
Gluten Pharmaceutical reported a net profit of ₹81,920 (net margin 8.2%) and EBITDA of ₹1.09 Lakh (EBITDA margin 11%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gluten Pharmaceutical is 42% over three years and 9% over five years. In the latest year (FY 2025) revenue rose 49%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gluten Pharmaceutical is 23AAFCG8835P2Z0, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Gluten Pharmaceutical is U24100MP2015PTC033832. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gluten Pharmaceutical was incorporated on 12 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Gluten Pharmaceutical by revenue are Bhura Tea Company Private Limited, Krishnangi Artwork Private Limited, Sterling Tubes and Valves Private Limited, MLV Tradecorp Limited, Reydis Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Somdev Urmaliya ceased to be Director on 10 Nov 2021. Meera Urmaliya was appointed as Director on 12 Feb 2015. Vikash Urmaliya Dev was appointed as Director on 12 Feb 2015.
The registered office of Gluten Pharmaceutical is at First Floor Puja Colony Neelbarh, Bhopal, Madhya Pradesh, India – 462001.